You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

salivary gland squamous cell carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharynx

Active, not recruiting
Has Results
  • Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With

Completed
Has Results
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +35 more
  • PI3K inhibitor BKM120
  • cetuximab
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Sep 14, 2021

Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell

Active, not recruiting
  • Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
  • +29 more
  • Cytology specimen
  • Laboratory biomarker analysis
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Aug 31, 2021

Bladder Cancer, Head and Neck Squamous Cell Carcinoma, Cancer of the Salivary Gland Trial in Houston (CAdVEC)

Recruiting
  • Bladder Cancer
  • +9 more
  • CAdVEC
  • Houston, Texas
    Baylor St. Luke's Medical Center
Feb 17, 2022

Head Neck Cancer, Head and Neck Tumors, Head and Neck Squamous Cell Carcinoma Trial in Copenhagen (Liquid biopsy)

Recruiting
  • Head and Neck Cancer
  • +26 more
  • Liquid biopsy
  • Copenhagen, Region Hovedstaden, Denmark
    University Hospital of Copenhagen, Rigshospitalet
Sep 14, 2021

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Completed
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Nov 29, 2022

Salivary LINC00657 asDiagnostic Biomarker for Oral Squamous Cell

Completed
  • Oral Squamous Cell Carcinoma
    • Fayoum, Egypt
      faculty of dentistry, Fayoum university
    Apr 19, 2023

    Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)

    Recruiting
    • Oral Cancer
    • Oral Squamous Cell Carcinoma
    • ELISA
    • Fayoum, Egypt
      Fayoum University
    Sep 8, 2023

    Immune Biomarker Study for Salivary Gland Carcinoma

    Not yet recruiting
    • Salivary Gland Tumor
    • Benign Salivary Gland Tumor
    • Sampling
    • Erlangen, Bavaria, Germany
    • +1 more
    Sep 21, 2023

    Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)

    Not yet recruiting
    • Advanced Salivary Gland Carcinoma
    • Shanghai, China
      Dongmei Ji
    Jun 21, 2023

    The Long Non Coding MALAT1 asPotential Salivary Diagnostic

    Completed
    • Oral Cancer Biomarkers
      • Giza, Egypt
        Rania Hassan Shalby
      Jan 31, 2023

      Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

      Recruiting
      • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
      • +2 more
      • Beijing, Beijing, China
      • +1 more
      Nov 21, 2023

      Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination

      Not yet recruiting
      • Salivary Gland Cancer
      • vedicitumomab (Edisil, RC48）
      • +3 more
      • (no location specified)
      Jun 9, 2023

      High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)

      Recruiting
      • High-grade Salivary Gland Carcinoma
      • nivolumab, docetaxel, cisplatin Group
      • Seoul, Korea, Republic of
        Department of Medicine, Samsung Medical Center, Sungkyunkwan Uni
      Feb 3, 2023

      Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

      Recruiting
      • Salivary Gland Cancer
      • Nagoya, Aichi, Japan
      • +11 more
      Jan 21, 2023

      Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)

      Recruiting
      • Salivary Gland Cancer
      • +2 more
      • Nijmegen, Gelderland, Netherlands
        Radboudumc
      Oct 27, 2022

      OSCC Identified By Liquid Chromatography Mass Spectroscopy

      Recruiting
      • Oral Squamous Cell Carcinoma
      • Oral Squamous Cell Carcinoma
      • Dhaka, Dhanmondi, Bangladesh
      • +1 more
      Feb 20, 2022

      Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

      Not yet recruiting
      • Locally Advanced Salivary Gland Carcinoma
      • +3 more
      • Biopsy
      • +3 more
      • (no location specified)
      Jan 10, 2023

      Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

      Recruiting
      • Salivary Gland Carcinoma
      • Chicago, Illinois
      • +6 more
      Sep 22, 2022

      Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

      Recruiting
      • Metastatic Salivary Gland Carcinoma
      • +4 more
      • New York, New York
        Memorial Sloane Kettering Cancer Center
      Jan 11, 2023

      Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in United States (Lenvatinib, Pembrolizumab)

      Recruiting
      • Adenoid Cystic Carcinoma
      • Salivary Gland Cancer
      • Miami, Florida
      • +7 more
      Oct 26, 2022

      Salivary Gland Cancer, Salivary Duct Carcinoma Trial in Nijmegen (68Ga-PSMA-PET/CT, 18FDG-PET/CT)

      Recruiting
      • Salivary Gland Cancer
      • Salivary Duct Carcinoma
      • 68Ga-PSMA-PET/CT
      • 18FDG-PET/CT
      • Nijmegen, Gelderland, Netherlands
        Radboudumc
      Aug 15, 2022

      Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

      Withdrawn
      • Salivary Gland Carcinoma
      • +3 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Feb 5, 2022

      Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Head and Neck Squamous Cell Carcinoma
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 25, 2023